Role of ayurveda treatment protocol(siravedha,lekhan basti,uttar basti) in garbhashaygata Arbuda with special reference to uterine fibroid

Clinical Study To Evaluate The Efficacy Of Ayurveda Treatment Protocol In The Management Of Garbhashayagata Arbuda W.S.R To Uterine Fibroid-A Proof Of Concept Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085454

Enrollment

Registered

2025-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D259- Leiomyoma of uterus, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female patient of age of 25-50 2.Having fibroid size upto 5 cm or less(confirmed by U.S.G) 3.Single fibroid 5 cm or multiple small fibroids(2-3) 4.Only married females

Exclusion criteria

Exclusion criteria: 1. Known case of malignancy of any system of body. 2. Patient having bleeding due to abortion or any pathological condition. 3. Patients having coagulation disorders. 4. Patients having IUCDs in-situ. 5. Patient having fibroid larger than 5cm. 6. Pregnancy with fibroid. 7. Anaemic patient whose haemoglobin is below 8% 8. Known case of chronic systemic illness- uncontrolled diabetes mallitus,hypertension, thyroid disorders, epilepsy, tuberculosis. 9. Known case of positive sexually transmitted disease (STDs) ,HIV, Hepatitis B,VDRL.

Design outcomes

Primary

Measure	Time frame
change in the size of Garbhashaygata ArbudaTimepoint: 90days	—

Secondary

Measure	Time frame
Change in the presenting symptoms of Garbhashaygata ArbudaTimepoint: 120days	—

Countries

India

Contacts

Public ContactDr Nandini Tirole

National Institute of Ayurveda

baruhunt@gmail.com9799997940

Outcome results